Successful Cancer Treatment in Dogs Could Lead to Treatment for Humans

Using a concept developed at the University of Kansas Hospital, an experimental injectable chemotherapy treatment being tested at the University of Missouri is utilizing a targeted approach to delivering chemotherapy. By injecting chemotherapy directly into the cancer, this form of treatment delivers more chemo where it’s needed and with fewer side effects, like hair loss. Within a couple of years doctors hope to see the first human trials. Learn More >

Gene Replacement Therapy Offers Viable Treatment Option for Fatal Disease

Researchers at the University of Missouri have developed a gene replacement therapy for spinal muscular atrophy with respiratory distress type 1 (SMARD1). The new therapy is able to cross the protective blood-brain barrier and target affected motor neurons in a non-invasive manner. Learn More >

Through Clinical Trials K-State Veterinarian Fights Cancer in Animals and possibly Humans

Rina DeBarthe of Olathe received the world’s tiniest pacemaker, the Micra, in January at Saint Luke’s Mid America Heart Institute as part of the clinical trial. Unlike other pacemakers, the Micra pacemaker has no wires and is inserted directed into the heart. The device received FDA approval last month. Learn More >

Click here for a full list of stories.

Share:

Interested in Getting more involved with BioNexus KC and our events?